NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘pharmaceutical’

25 August 2015

Bain Capital backs sterile compound pharma manufacturer QuVa

pills-530372_1280 Bain Capital has bought a majority stake in new sterile compounding pharmacy services platform QuVa Pharma.

22 June 2015

CVC, Temasek take stake in Pamplona-backed pharma company Alvogen

pills-384846_1280 A consortium including CVC Capital Partners and Singapore sovereign investor Temasek is set to buy a controlling stake in Pamplona-backed pharmaceutical company Alvogen.

16 June 2015

Sequoia backs Indian pharma business La Renon with $15.5m

aspirin-156974-m Sequoia Capital has invested INR1bn ($15.5m) in Indian pharmaceutical research, marketing and manufacturing business La Renon Healthcare.

10 June 2015

Fulcrum Venture India hits INR1bn final close for second healthcare, pharma fund

rupees-533387-m Early-stage investor Fulcrum Venture India has beaten its target for its latest healthcare and pharmaceutical fund by closing the vehicle on INR1bn ($15.6m).

1 May 2015

VC-backed Blueprint Medicines floats raising $147m

news_blueprint_lrg Third Rock Ventures-backed enzyme specialist Blueprint Medicines Corp has launched its IPO on the New York Stock Exchange raising $147m.

9 April 2015

Venture capital-backed protein biologics company aTyr Pharma files for IPO

download (4) Rare disease specialist aTyr Pharma, whose venture capital backers include Alta Partners, Cardinal Partners and Domain Associates, has filed for an IPO.

16 March 2015

TPG-backed Par Pharmaceutical registers for IPO

clinic health drugs pharma Generic drugmaker Par Pharmaceutical Holdings, which is owned by TPG has filed for an initial public offering and stated its nominal target as $100m.

13 March 2015

NEA, Hatteras reup in PhaseBio through $40m Series C round

heart_lrg New Enterprise Associates and Hatteras Venture Partners have renewed their commitment to PhaseBio Pharmaceuticals through a $40m Series C round.

17 February 2015

Versant, Frazier drive $30m Series B for US company Laguna Pharmaceuticals

BPL monitor Healthcare investors Versant Ventures and Frazier Healthcare have led a $30m financing round for cardia arrhythmia-focused Laguna Pharmaceuticals.

27 January 2015

China’s Legend Capital heads up $100m Series C for Innovent Biologics

pharmaceutical 12_sq Beijing-based venture capital firm Legend Capital has led a $100m Series C funding round for Chinese biopharmaceutical company Innovent Biologics.

Page 1 of 2012345...1020...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015